Emmessar Biotech & Nutrition Ltd
₹25.91
(-3.64%)
Tue, 03 Mar 2026, 03:05 pm
Health Technology
Pharmaceuticals: Other
24.5KEmmessar Biotech & Nutrition Price to Cash Flow Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.57 | 16.83 | 16.73 | 7.56 | 5.07 | 28.90 | 24.59 | 19.81 | 48.02 |
| Price to book ratio | 0.64 | 0.80 | 1.50 | 0.99 | 0.90 | 1.40 | 6.91 | 5.53 | 6.01 | 5.16 | 2.54 | 1.34 | 1.29 | 2.23 | 1.86 | 2.01 | 1.97 |
| Price to sales ratio | 0.30 | 0.34 | 0.83 | 0.66 | 3.01 | 1.61 | 4.33 | 2.55 | 4.77 | 12.28 | 14.17 | 1.68 | 1.05 | 37.65 | 12.16 | 26.74 | 24.85 |
| Price to cash flow ratio | 10.58 | 0 | 0 | 0 | 0 | 592.03 | 0 | 11.40 | 16.68 | 20.87 | 29.43 | 4.71 | 12.41 | 5.70 | 19.46 | 15.49 | 18.82 |
| Enterprise value | 16.19M | 18.5M | 31.72M | 20.52M | 17.12M | 21.73M | 94.63M | 45.93M | 122.41M | 151.13M | 82.68M | 38.07M | 48.66M | 91.47M | 72.72M | 87.66M | 83.01M |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 370.97 | 51.03 | 0 | 0 | 0 | 5.74 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.01 | 0.01 | 0 |
| Return on equity % | 0 | -6.01 | -12.11 | -1.21 | -9.03 | -17.39 | -7.98 | -40.75 | 79.27 | 36 | 16.42 | 19.40 | 29.10 | 8.01 | 7.85 | 10.66 | 4.19 |
Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio
The Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Emmessar Biotech & Nutrition Ltd's valuation, profitability, and overall financial performance. Tracking the Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Emmessar Biotech & Nutrition Ltd (NSE: , BSE: 524768) is currently trading at ₹25.91, with a market capitalization of ₹129.45M. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio Current Value
The current Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio stands at 18.82.
The latest Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio Historical Trend
The Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 18.82
- 2023: 15.49
- 2022: 19.46
- 2021: 5.70
- 2020: 12.41
The recent rise in Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio suggests strengthening valuation trends and improving market sentiment.
What Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio Indicates for Investors
The Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio Analysis Summary
The Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800